Physician profile
Joyce Kate Forest
NPI 1730334665
$4,740.38
in general payments reported to CMS, 2019-2025
25 companies · $21.82 in 2025
The $21.82 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2020: $304 · 2021: $681 · 2022: $1,708 · 2023: $677 · 2024: $839 · 2025: $21.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,499 · Education: $38.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,498.65 |
| Education | $38.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,411.43 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $423.17 | 2021-2024 | Dupixent, Libtayo |
| Amgen INC. | $409.37 | 2019-2024 | Otezla, Enbrel |
| Genzyme Corporation | $365.15 | 2021-2024 | |
| Janssen Biotech, INC. | $270.31 | 2021-2024 | Tremfya, Simponi Aria, Stelara |
| Ucb, INC. | $238.12 | 2019-2024 | Bimzelx |
| Pfizer INC. | $207.12 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $180.61 | 2019-2024 | |
| Incyte Corporation | $172.90 | 2021-2022 | |
| Lilly USA, LLC | $167.38 | 2021-2022 | |
| Almirall LLC | $127.25 | 2022 | |
| Janssen Scientific Affairs, LLC | $121.88 | 2022 | |
| Sun Pharmaceutical Industries INC. | $116.57 | 2020-2022 | |
| Galderma Laboratories, L.P. | $96.63 | 2019-2023 | |
| Leo Pharma INC. | $92.07 | 2022-2024 | Adbry |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $88.35 | 2022-2024 | Sotyktu |
| Boston Scientific Corporation | $73.07 | 2024-2025 | General - Pain Management, Lux-Dx Insertable Cardiac Monitor, Accolade Sr |
| Kyowa Kirin, INC. | $38.90 | 2021-2022 | |
| Dermavant Sciences, INC. | $27.35 | 2024 | Vtama |
| Dermira, INC. | $24.20 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.21 | 2024 | Cyltezo |
| Arcutis Biotherapeutics, INC. | $19.65 | 2024 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.41 | 2019 | |
| Phadia US INC. | $16.37 | 2022 | |
| Mayne Pharma Commercial LLC | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Forest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.